SHR-1802

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-1802, covering 2023-06-02 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-1802 in Patients With Advanced Solid Tumor [Phase 2]